Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China
- PMID: 32900569
- DOI: 10.1016/j.numecd.2020.07.028
Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China
Abstract
Background and aims: The aim of this study was to evaluate the association between body mass index (BMI) and mortality in atrial fibrillation (AF) patients with and without diabetes mellitus (DM).
Methods and results: A total of 1991 AF patients were enrolled and divided into two groups according to whether they have DM at recruitment. Baseline information was collected and a mean follow-up of 1 year was carried out. The primary outcome was defined as all-cause mortality with the secondary outcomes including cardiovascular mortality, stroke and major adverse events (MAEs). Univariable and multivariable Cox regression were performed to estimate the association between BMI and 1-year outcomes in AF patients with and without DM. 309 patients with AF (15.5%) had comorbid DM at baseline. Patients with DM were more likely to have cardiovascular comorbidities, receive relevant medications but carry worse 1-year outcomes. Multivariable Cox regressions indicated that elevated BMI was related with reduced risk of all-cause mortality, cardiovascular mortality and major adverse events. Compared to normal weight, overweight [HR (95% CI): 0.548 (0.405-0.741), p < 0.001] and obesity [HR (95% CI): 0.541 (0.326-0.898), p = 0.018] were significantly related with decreased all-cause mortality for the entire cohort. Remarkably reduced all-cause mortality in the overweight [HR (95% CI): 0.497 (0.347-0.711), p < 0.001] and obesity groups [HR (95% CI): 0.405 (0.205-0.800), p = 0.009] could also be detected in AF patients without DM, but not in those with DM.
Conclusion: Elevated BMI was associated with reduced mortality in patients with AF. This association was modified by DM. The obesity paradox confined to AF patients without DM, but could not be generalized to those with DM.
Keywords: All-cause mortality; Atrial fibrillation; Body mass index; Diabetes mellitus.
Copyright © 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.J Am Heart Assoc. 2020 Jan 7;9(1):e013789. doi: 10.1161/JAHA.119.013789. Epub 2019 Dec 24. J Am Heart Assoc. 2020. PMID: 31870235 Free PMC article.
-
Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study.Clin Res Cardiol. 2019 Dec;108(12):1371-1380. doi: 10.1007/s00392-019-01473-3. Epub 2019 Apr 5. Clin Res Cardiol. 2019. PMID: 30953181
-
Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry.J Cardiovasc Electrophysiol. 2018 Apr;29(4):566-572. doi: 10.1111/jce.13428. Epub 2018 Feb 1. J Cardiovasc Electrophysiol. 2018. PMID: 29345382
-
Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies.Pacing Clin Electrophysiol. 2013 Jun;36(6):748-56. doi: 10.1111/pace.12106. Epub 2013 Feb 25. Pacing Clin Electrophysiol. 2013. PMID: 23437987
-
Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.Cardiovasc Diabetol. 2022 Mar 14;21(1):39. doi: 10.1186/s12933-022-01473-0. Cardiovasc Diabetol. 2022. PMID: 35287684 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical